ARNTL2, with an impact on metastatic capacity in vivo and clonal growth in cell culture, is capable of making lung adenocarcinoma metastatic self-sufficiency through an Arntl2-driven secretome [33]. Here, BMAL2 is linked to lung adenocarcinoma.